Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Symbol: 
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
10/15/20247:53AMBusiness WireAccenture’s Next Generation Robotics GTM Lead and AI-Expert Dr. Maria Danninger joins Circus Group Advisory Board
10/15/20247:51AMAlliance NewsAlliance News*AngloGold: sanction of deal at Jersey court meeting is remaining hurdle for Centamin buyLSE:CEYCentamin Plc
10/15/20247:51AMPR Newswire (US)Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA TestNASDAQ:PAVMPAVmed Inc
10/15/20247:51AMPR Newswire (US)Lucid Diagnostics Receives Notice of Allowance for Key Patent Underlying Its EsoGuard Esophageal DNA TestNASDAQ:LUCDLucid Diagnostics Inc
10/15/20247:50AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RDWRRADWARE Ltd
10/15/20247:50AMGlobeNewswire Inc.BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal StudyTSX:BCTBriaCell Therapeutics Corp
10/15/20247:50AMGlobeNewswire Inc.BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal StudyNASDAQ:BCTXWBriaCell Therapeutics Corporation
10/15/20247:50AMGlobeNewswire Inc.BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal StudyNASDAQ:BCTXBriaCell Therapeutics Corporation
10/15/20247:50AMAlliance NewsAlliance News*AngloGold says Centamin buy approval received from Egyptian Competition AuthorityLSE:CEYCentamin Plc
10/15/20247:50AMBusiness WireDelimex Expands Beyond Taquitos with Launch of New 360CRISP™ QuesadillasNASDAQ:KHCKraft Heinz Company
10/15/20247:50AMGlobeNewswire Inc.Landstar to Release Third Quarter Results on Tuesday, October 29, 2024NASDAQ:LSTRLandstar System Inc
10/15/20247:50AMGlobeNewswire Inc.ZyVersa Therapeutics CEO, Stephen C. Glover, Was a Featured Guest on The Big Biz Show to Discuss Current Trends in the Obesity Drug Market and the Potential Role of Inflammasome InhibitorsNASDAQ:ZVSAZyVersa Therapeutics Inc
10/15/20247:50AMPR Newswire (US)Easy-PC Celebrates 40 Years of Excellence in PCB Design with the Addition of Over 40 New Features
10/15/20247:49AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:QUREuniQure NV
10/15/20247:48AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
10/15/20247:48AMPR Newswire (US)DermCare Management Expands California Footprint with Partnership at Contour Dermatology & Cosmetic Surgery Center
10/15/20247:46AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:INGRIngredion Incorporated
10/15/20247:46AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
10/15/20247:46AMPR Newswire (US)Gan & Lee Pharmaceuticals' Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies
10/15/20247:45AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:LUVSouthwest Airlines Co
10/15/20247:45AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:INGRIngredion Incorporated
10/15/20247:45AMBusiness WireCore10’s Lee Farabaugh Elected to Board of Directors for Association for Financial Technology (AFT)
10/15/20247:45AMGlobeNewswire Inc.Trailbreaker Initiates Multiple Geophysical Surveys at the Liberty Copper-Molybdenum Project, British ColumbiaTBK.V
10/15/20247:45AMGlobeNewswire Inc.Trailbreaker Initiates Multiple Geophysical Surveys at the Liberty Copper-Molybdenum Project, British ColumbiaTSXV:TBKTrailbreaker Resources Ltd
10/15/20247:45AMPR Newswire (US)Mexico must define key sectors to leverage nearshoring, USMCA, experts say at EFE's forum
10/15/20247:45AMPR Newswire (Canada)Decisive Dividend Corporation Announces November 2024 DividendTSXV:DEDecisive Dividend Corporation
10/15/20247:45AMPR Newswire (US)Heartland Dental Featured on Emmy-Nominated Series, Tomorrow's World Today
10/15/20247:45AMPR Newswire (US)Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference
10/15/20247:44AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
10/15/20247:43AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co

Your Recent History

Delayed Upgrade Clock